Citigroup Inc Fusion Pharmaceuticals Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.9 - $21.32 $189,268 - $510,784	23,958 Added 1828.85%	25,268 $538,000
Q4 2023 Feb 09, 2024	BUY	$2.48 - $9.65 $3,248 - $12,641	1,310 New	1,310 $12,000
Q4 2021 Feb 10, 2022	SELL	$4.17 - $7.78 $10,066 - $18,780	-2,414 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$7.83 - $9.41 $18,901 - $22,715	2,414 New	2,414 $19,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.